Analysts expect Homology Medicines, Inc. (NASDAQ:FIXX – Get Rating) to report sales of $1.05 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Homology Medicines’ earnings, with the highest sales estimate coming in at $1.30 million and the lowest estimate coming in at $800,000.00. Homology Medicines posted sales […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Homology Medicines (NASDAQ:FIXX – Get Rating) had its price objective reduced by analysts at Credit Suisse Group to $2.10 in a research report issued to clients and investors on Tuesday, Stock Target Advisor reports. The firm presently has a “neutral” rating on the stock. Credit Suisse Group’s target price suggests a potential upside of 45.83% […]
Homology Medicines, Inc. (NASDAQ:FIXX – Get Rating) has been given a consensus rating of “Buy” by the eleven analysts that are covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among analysts that have […]
Homology Medicines (NASDAQ:FIXX – Get Rating) issued its earnings results on Wednesday. The company reported ($0.59) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.57) by ($0.02), MarketWatch Earnings reports. Homology Medicines had a negative net margin of 269.33% and a negative return on equity of 44.87%. FIXX stock traded down $0.16 during […]